Lv41
760 积分 2021-04-26 加入
Circulating Tumor DNA Assessment in Classic Hodgkin Lymphoma: Ready for Primetime?
21分钟前
已完结
Long-term efficacy, safety and neurotolerability of MATRix regimen followed by autologous transplant in primary CNS lymphoma: 7-year results of the IELSG32 randomized trial
2个月前
已完结
Fixed-Duration Acalabrutinib Combinations in Untreated Chronic Lymphocytic Leukemia
3个月前
已完结
Primary central nervous system lymphoma: Evolving treatment strategies to achieve improved long-term disease control
3个月前
已完结
Covalent and Non-Covalent BTK Inhibition in Chronic Lymphocytic Leukemia Treatment
6个月前
已完结
Zanubrutinib in patients with previously treated B-cell malignancies intolerant of previous Bruton tyrosine kinase inhibitors in the USA: a phase 2, open-label, single-arm study
7个月前
已完结
Tailored approaches in mantle cell lymphoma: refining treatment paradigms with an expert panel opinion
7个月前
已完结
Fixed-Duration versus Continuous Treatment for Chronic Lymphocytic Leukemia
7个月前
已完结
中国高危人群乙型肝炎病毒再激活防治指南(2026年版)
7个月前
已完结
New BTK Inhibitors May Combat Resistance in CLL
8个月前
已完结